Patient Chart Review: Real-world Patient Data That Connects The Dots Between Perception and Reality

Patient Chart Review: Real-world Patient Data That Connects The Dots Between Perception and Reality

The importance of real-world data (RWD) cannot be understated – it is a critical component of post-marketing surveillance and its use in pre-launch regulatory approvals is increasing with the FDA’s heightened emphasis on patient-focused drug development. The medical affairs use case for RWD is clear, but what about the use case for the commercial side of a pharmaceutical company?  


The simple answer: it’s an incredible tool for developing more effective sales and marketing strategies. The insights from RWD are even more powerful when paired with primary research with the healthcare providers who are the key to product uptake.  


Ultimately, this type of research effort helps pharmaceutical manufacturers capitalize on opportunities, identify the barriers to overcome, and bridge gaps in their secondary data, answering critical questions such as:  KJT enables clients to gain insights like these through Patient Chart Review, where retrospective data is extracted from patient medical records (through a custom digital form) and is coupled with an online survey to ensure you get a full view of provider perceptions and their real-world care practices. This approach enhances data accuracy by minimizing the impact of recall issues, provides more granularity than a “typical patient” survey approach, and is an efficient way to collect a wealth of data. As appropriate, qualitative interviews are also included to explore the deeper “whys” and illuminate reasons for atypical care experiences.  


Ultimately, marrying individual level patient data with broader assessments of providers’ practice habits and perceptions provides a richer and more holistic assessment of the treatment landscape. This research approach is also beneficial when developing forecast models – utilizing multiple data sources ensures a more accurate and robust picture of a market. Estimates of market share, uptake timing, size of relevant patient populations, likelihood of product switching, etc. can certainly be gathered as part of a survey, but patient chart data can provide more accuracy and reliability for these important inputs, as well as enable measurement of inputs such as dosing frequency and strength – all of which may be critical components of the base layer of your forecast model’s estimate of product use. In markets where secondary prescribing data is difficult to obtain, this integration is even more valuable for projecting sample HCP prescribing behavior to a larger population. 

Ultimately, KJT combines the data sourced from this research with custom advanced analytics to marry the survey and chart data together and turn it into a model of the real-world patterns of disease progression, diagnosis, and treatment. This illuminates how providers help their patients (as unique individuals), their higher-level approach to care, as well as the care gaps that exist.  

How can you learn more about how KJT can help you? 
Patient Chart Review is an efficient and effective way to ensure you have a full understanding of the patient care landscape that could impact your product through real-world evidence generation. KJT has a wealth of experience conducting digital patient chart reviews that support clients’ need for real-world evidence.  

Have a question, want to learn more, or just want to say hello?

We’d love to hear from you. Fill out the form and we will be in touch.

Blogs & News

Read More
Read More

Empathy, Integrity, and Mindfulness: The Values that Drive Innovation at KJT 

We are immensely proud of our journey from a nascent market research firm in 2007 to a recognized…

Read More
Read More

Generative AI Message Testing – Does it Really Work? 

Message testing is a crucial process for pharmaceutical and biotech companies when evaluating the…

Read More
healthcare provider using generative AI tools
Read More

Using Generative AI for Patient-Centered Market Research – Reality or Myth? 

No matter where you look, generative AI is becoming commonplace. In the realm of healthcare…

Read More
Read More

3 Reasons Why Working in an ESOP Company is Inspiring

When I first came to the United States from Scotland, I wasn’t fully familiar with the idea of…

Read More
Read More

KJT Welcomes Laura McCormick, PhD

KJT is delighted to announce the appointment of Laura McCormick, PhD as the new Vice President of…

Read More
Read More

Finding the Path to Your Brand’s North Star: The Importance of Enhancing Brand Equity & Tracking Research

In the competitive pharmaceutical and biotech landscapes, the strength of a brand can often be the…

Read More
Read More

KJT Welcomes Melissa Usseglio, Senior Vice President of Client Strategy

KJT is thrilled to announce the hiring of Melissa Usseglio as Senior Vice President of Client…

Read More
Read More

Uncovering the Realities of Rare Disorders from the Patient’s Perspective

The world of rare diseases and the impact it has on countless lives is often underestimated. Rare…

Read More
Elderly lady with nurse
Read More

4 Ways to Enhance Care for Patients with Rare Diseases

The unique value of integrating the patient voice into the development process of therapies…

Read More
Read More

Using Evidence from the Exam Room to Shape RWE Strategy

Traditional methods for generating real-world evidence (RWE) from patient-physician conversations…

Let’s Take Research Further. Together.